Low UBA7 gene expression was associated with poor survival as seen in CLL patients harboring SF3B1 mutations, suggesting its potential use as a biomarker for adverse prognostic outcomes. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.